A study to investigate the effect of food on balcinrenone/dapagliflozin pharmacokinetics in fed and fasted state and pharmacokinetics of balcinrenone when dosed with a P-gp inhibitor in healthy participants.

Trial Identifier: D6402C00009
Sponsor: AstraZeneca
Collaborator:
Parexel
Start Date: May 2025
Primary Completion Date: July 2025
Study Completion Date: August 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
GB Harrow, GB, HA1 3UJ